companydata.dkREPOS PHARMA ApS: Financial statements 2016
CVR: 35841555
REPOS PHARMA ApS (CVR 35841555) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK -63,417 compared with DKK -264,799 the year before. Equity amounted to DKK 1,805. The solvency ratio was 7.4%.
- Gross Profit
- 0 kr.
- Profit/Loss
- -63,417 kr.
- Equity
- 1,805 kr.
- Total Assets
- 24,305 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 0 | -63 t. | 2 t. | - |
| 2015 | - | -298 t. | -265 t. | 65 t. | - |
How creditworthy is REPOS PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
REPOS PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -298,039, and the net result was DKK -264,799.
As of April 19, 2016, Torsten Bjørn is registered as director of REPOS PHARMA ApS.
As of April 19, 2016, Henrik Lasse Lindblad has stepped down as adm. dir of REPOS PHARMA ApS.
About REPOS PHARMA ApS
REPOS PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2014 and dissolved in 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK -63,417 compared with DKK -264,799 the year before. Equity amounted to DKK 1,805.